Common Contracts

EX-2.6 7 a17-3513_1ex2d6.htm EX-2.6 INTELLECTUAL PROPERTY LICENSE AGREEMENT between BIOGEN INC. and BIOVERATIV INC. Dated as of February 1, 2017 Page

Intellectual Property License Agreement • May 5th, 2020 • Delaware

• Contract Type
  Intellectual Property License Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Delaware

INTELLECTUAL PROPERTY LICENSE AGREEMENT between BIOGEN INC. and BIOVERATIV INC. Dated as of February 1, 2017

Intellectual Property License Agreement • February 2nd, 2017 • Bioverativ Inc. • Pharmaceutical preparations • Delaware

• Contract Type
  Intellectual Property License Agreement
• Filed
  February 2nd, 2017
• Company
  Bioverativ Inc.
• Industry
  Pharmaceutical preparations
• Jurisdiction
  Delaware

This INTELLECTUAL PROPERTY LICENSE AGREEMENT (this “Agreement”) is made and effective as of February 1, 2017 (the “Effective Date”) by and between Bioverativ Inc. (“Bioverativ”), a Delaware corporation, and Biogen Inc. (“Biogen”), a Delaware corporation (each of Bioverativ and Biogen being a “Party,” and collectively, the “Parties”).